Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.
Masimo Corp. didn’t have to go far to find its next chief executive. The Irvine-based medical device maker last week announced that it tapped Edwards Lifesciences Corp. veteran Katie Szyman as CEO, ...
Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...
Masimo, the patient monitoring company known for its pulse oximetry devices, said Tuesday it has hired Katie Szyman as its next CEO. Szyman is worldwide president of advanced patient monitoring at ...
IRVINE, Calif.--(BUSINESS WIRE)--Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the ...
Masimo Corp. selected Catherine (Katie) Szyman, an industry leader with deep med-tech roots, to guide the company as it seeks to rebuild its reputation and revenues following a gritty two-year battle ...
Needham analyst Michael Matson has maintained their neutral stance on MASI stock, giving a Hold rating on January 17. Michael Matson’s rating is based on a combination of factors regarding ...
Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...
Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has been appointed Chairman of Masimo’s Board and Lead ...
Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...